John Overdeck Two Sigma Investments
John Overdeck is a co-founder of Two Sigma Investments, one of the world’s leading quantitative and technology-driven investment firms. Two Sigma applies data science, machine learning, and large-scale computing to markets across asset classes. Overdeck’s firm is a central reference point in discussions of modern systematic investing.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AT&T
T
|
+$166M |
| 2 |
Chevron
CVX
|
+$163M |
| 3 |
Amazon
AMZN
|
+$162M |
| 4 |
Comcast
CMCSA
|
+$160M |
| 5 |
Target
TGT
|
+$158M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Elevance Health
ELV
|
+$165M |
| 2 |
Cisco
CSCO
|
+$161M |
| 3 |
Biogen
BIIB
|
+$158M |
| 4 |
AET
Aetna Inc
AET
|
+$156M |
| 5 |
Hewlett Packard
HPE
|
+$155M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Consumer Discretionary | 13.51% |
| 2 | Technology | 12.14% |
| 3 | Industrials | 11.33% |
| 4 | Healthcare | 10.15% |
| 5 | Communication Services | 8.96% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
76
CALL
State Street SPDR S&P 500 ETF Trust
SPY
$809B
| $79M | 0.27% |
335,200
+230,800
| +221% | +$53.6M |
|
77
AbbVie
ABBV
$468B
| $78.6M | 0.26% |
1,206,865
-126,159
| -9% | -$7.93M |
|
78
Liberty Global Class A
LBTYA
$3.63B
| $78M | 0.26% |
2,174,636
+29,306
| +1% | +$1.04M |
|
79
Burlington
BURL
$20.6B
| $77.5M | 0.26% |
796,776
+28,023
| +4% | +$2.48M |
|
80
Royal Caribbean
RCL
$78.1B
| $77.1M | 0.26% |
785,562
+500,363
| +175% | +$46.8M |
|
81
Darden Restaurants
DRI
$25.2B
| $76.7M | 0.26% |
917,045
+721,019
| +368% | +$54M |
|
|
VIAB
82
DELISTED
Viacom Inc. Class B
VIAB
| $76.4M | 0.26% |
1,638,251
+1,118,829
| +215% | +$47.2M |
|
83
Annaly Capital Management
NLY
$17.5B
| $76.2M | 0.26% |
1,714,755
+526,262
| +44% | +$22.4M |
|
84
Bath & Body Works
BBWI
$3.92B
| $74.8M | 0.25% |
+1,965,103
| New | +$88.6M |
|
85
ServiceNow
NOW
$133B
| $74M | 0.25% |
+4,230,215
| New | +$73.8M |
|
86
Air Products & Chemicals
APD
$67.9B
| $73.7M | 0.25% |
545,078
-241,581
| -31% | -$34.1M |
|
|
WR
87
DELISTED
Westar Energy Inc
WR
| $73.6M | 0.25% |
1,356,796
| – | – |
|
|
PX
88
DELISTED
Praxair Inc
PX
| $73.1M | 0.25% |
616,542
+552,753
| +867% | +$65M |
|
89
Bunge Global
BG
$21.7B
| $71.8M | 0.24% |
905,805
+593,094
| +190% | +$44.4M |
|
90
PUT
Pfizer
PFE
$160B
| $70.6M | 0.24% |
2,175,667
+1,617,890
| +290% | +$51M |
|
91
Vertex Pharmaceuticals
VRTX
$139B
| $70.6M | 0.24% |
645,430
-381,425
| -37% | -$33.6M |
|
92
Oneok
OKE
$58.8B
| $69.4M | 0.23% |
1,252,445
+1,200,784
| +2,324% | +$66M |
|
93
Sabre
SABR
$848M
| $68.8M | 0.23% |
3,247,615
+2,420,069
| +292% | +$55.4M |
|
94
Mondelez International
MDLZ
$82.3B
| $67.3M | 0.23% |
1,562,745
+1,324,349
| +556% | +$58.7M |
|
|
ATH
95
DELISTED
Athene Holding Ltd. Class A Common Shares
ATH
| $67.3M | 0.23% |
+1,345,526
| New | +$66.8M |
|
|
AGU
96
DELISTED
Agrium
AGU
| $67.1M | 0.23% |
702,148
+229,978
| +49% | +$23.2M |
|
|
POT
97
DELISTED
Potash Corp Of Saskatchewan
POT
| $67M | 0.23% |
3,925,354
+827,803
| +27% | +$15M |
|
|
BEAV
98
DELISTED
B/E Aerospace Inc
BEAV
| $66.9M | 0.23% |
1,043,857
+372,277
| +55% | +$23.3M |
|
99
ExxonMobil
XOM
$679B
| $66.7M | 0.22% |
+812,964
| New | +$67.9M |
|
100
Omnicom Group
OMC
$24B
| $66.5M | 0.22% |
771,829
+668,754
| +649% | +$57.1M |
|
Similar funds
John Overdeck's Q1 2017 Portfolio in Review
As of Q1 2017, John Overdeck held 3,630 positions worth $29.7B, up 14% from $26.1B the previous quarter. Its ten largest holdings account for 6% of the portfolio.
John Overdeck deployed $1.88B of net new capital in Q1 2017, opening 608 new positions and adding to 1,072 existing holdings. Its largest new stake was Amazon: 3,886,480 shares worth $172M.
By sector, the portfolio is most concentrated in Consumer Discretionary at 14% of assets, up from 9.9% a quarter earlier, followed by Technology and Industrials.
On the sell side, the largest reduction was Cisco, an estimated $161M trimmed.
- John Overdeck's largest Q1 2017 buy was Amazon: 3,886,480 shares worth $172M.
- John Overdeck added most to AT&T in Q1 2017, an estimated $166M increase.
- John Overdeck's biggest Q1 2017 reduction was Cisco, cutting an estimated $161M.
- John Overdeck fully exited Elevance Health in Q1 2017, selling an estimated $165M.
- John Overdeck's ten largest holdings make up 6% of its $29.7B portfolio in Q1 2017.
- John Overdeck opened 608 new positions and closed 801 in Q1 2017.
- John Overdeck's portfolio value rose 14% quarter-over-quarter to $29.7B.
Based on Two Sigma Investments's 13F filing for Q1 2017, filed 15 May 2017.